Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Sara Naimimohasses"'
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
With recent advancements in deep learning (DL) techniques, the use of artificial intelligence (AI) has become increasingly prevalent in all fields. Currently valued at 9.01 billion USD, it is a rapidly growing market, projected to increase by 40% per
Externí odkaz:
https://doaj.org/article/b2da2ac99bff492b999e0e0821aa8b6d
Autor:
Hannah Wozniak, Sara Naimimohasses, Toru Goto, Gonzalo Sapisochin, Blayne Sayed, Anand Ghanekar, Mark Cattral, Nazia Selzner
Publikováno v:
Journal of Transplantation, Vol 2024 (2024)
The increasing prevalence of steatotic liver disease (SLD) in potential living donors is concerning, as it limits donor’s availability amid rising demand. OPTIFAST very low-calorie diet (VLCD), a meal replacement product, effectively reduces weight
Externí odkaz:
https://doaj.org/article/843e8cd9a20e46e29f45a0732e336bdb
Autor:
Cristina Baciu, Soumita Ghosh, Sara Naimimohasses, Arya Rahmani, Elisa Pasini, Maryam Naghibzadeh, Amirhossein Azhie, Mamatha Bhat
Publikováno v:
Metabolites, Vol 14, Iss 5, p 254 (2024)
Graft injury affects over 50% of liver transplant (LT) recipients, but non-invasive biomarkers to diagnose and guide treatment are currently limited. We aimed to develop a biomarker of graft injury by integrating serum metabolomic profiles with clini
Externí odkaz:
https://doaj.org/article/c5981f52eb44444e929c6d44c3c73dbd
Autor:
Damien Ferguson, Suzanne Norris, Marie McGrath, Philip O'Gorman, Sara Naimimohasses, Emma McCormick, Ann Monaghan, Mark W Robinson, John Gormley
Publikováno v:
BMJ Open Gastroenterology, Vol 9, Iss 1 (2022)
Objective End-stage chronic liver disease is associated with accelerated ageing and increased frailty. Frailty measures have provided clinical utility in identifying patients at increased risk of poor health outcomes, including those awaiting liver t
Externí odkaz:
https://doaj.org/article/790e5efe6474461ea38ca3cd84a0a830
Autor:
Sara Naimimohasses, Philip O’Gorman, Ciara Wright, Deirdre Ni Fhloinn, Dean Holden, Niall Conlon, Ann Monaghan, Megan Kennedy, John Gormley, Peter Beddy, Stephen Patrick Finn, Joanne Lysaght, Jacintha O’Sullivan, Margaret R. Dunne, Suzanne Norris, J. Bernadette Moore
Publikováno v:
Nutrients, Vol 14, Iss 11, p 2198 (2022)
Background: Mucosal-associated invariant T (MAIT) cells promote inflammation in obesity and are implicated in the progression of non-alcoholic fatty liver disease (NAFLD). However, as the intrahepatic MAIT cell response to lifestyle intervention in N
Externí odkaz:
https://doaj.org/article/16eaf5f14e4c4d0787177e86669ff8d1
Autor:
Sara Naimimohasses, Omar El Sherif, Mohammad Ashfaq, Niamh Nolan, Masood Iqbal, Susan McKiernan, Suzanne Norris
Publikováno v:
Case Reports in Gastroenterology, Vol 11, Iss 3, Pp 797-802 (2017)
The spontaneous seroclearance of hepatitis B upon development of a hepatocellular carcinoma (HCC) is extremely rare. To date, there has been one published case series reporting hepatitis B seroconversion following HCC resection. We describe two novel
Externí odkaz:
https://doaj.org/article/83b630b25b754b2aa004af58c872c377
Genomic Analysis of Hair From Celebrated Composer Provides Insight Into Liver Disease Susceptibility
Autor:
Sara Naimimohasses, Mamatha Bhat
Publikováno v:
Gastroenterology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52b881561fba6ba9d16fc020e5f56ebd
https://doi.org/10.1053/j.gastro.2023.04.020
https://doi.org/10.1053/j.gastro.2023.04.020
Autor:
Sara Naimimohasses, Philip O'Gorman, Emma McCormick, Damien Ferguson, Ann Monaghan, Marie McGrath, Mark W Robinson, John Gormley, Suzanne Norris
Publikováno v:
BMJ Open Gastroenterology. 9:e000861
ObjectiveEnd-stage chronic liver disease is associated with accelerated ageing and increased frailty. Frailty measures have provided clinical utility in identifying patients at increased risk of poor health outcomes, including those awaiting liver tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1502e6bb6e275c9aff3fea032ac28d
https://doi.org/10.1136/bmjgast-2021-000861
https://doi.org/10.1136/bmjgast-2021-000861
Autor:
Philip, O'Gorman, Sara, Naimimohasses, Ann, Monaghan, Megan, Kennedy, Stephen P, Finn, J Bernadette, Moore, John, Gormley, Suzanne, Norris
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 52(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a89733e1819e3244e6fc4b9126736737
https://pubmed.ncbi.nlm.nih.gov/33105976
https://pubmed.ncbi.nlm.nih.gov/33105976
Autor:
Suzanne Norris, Stephen P. Finn, John Gormley, Derek G. Doherty, Megan Kennedy, Sara Naimimohasses, Deirdre Ní Fhloinn, Philip O'Gorman, J. Bernadette Moore, Ann Monaghan, Peter Beddy, Ashanty M. Melo
Publikováno v:
Alimentary Pharmacology & Therapeutics.
Background Lifestyle interventions are the primary treatment for metabolic (dysfunction) associated fatty liver disease (MAFLD). However, the histological and cardiometabolic effects of aerobic exercise in MAFLD remain unclear. Aims To assess the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71490bd358bb3a99961c826ec6c7991e
https://doi.org/10.1111/apt.15989
https://doi.org/10.1111/apt.15989